Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove

Optimizing HCC Organoid Formation for Target Identification and Drug Development

August 18th, 2023
*1,2, *3, *1,2, 4, 4, 1,2, 1,2, 1,2, 4, 1,2, 1,2
1Affiliated Cancer Hospital and Institute of Guangzhou Medical University, 2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Center for Cancer Research and Translational Medicine, School of Basic Medical Sciences, Guangzhou Medical University, 3Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, 4Department of Hepatobiliary Surgery, Affiliated Cancer Hospital, Guangzhou Medical University
* These authors contributed equally

Summary
Automatic Translation

Vi tillhandahåller en omfattande översikt och förfining av befintliga protokoll för organoidbildning av hepatocellulärt karcinom (HCC), som omfattar alla stadier av organoidodling. Detta system fungerar som en värdefull modell för identifiering av potentiella terapeutiska mål och bedömning av läkemedelskandidaters effektivitet.

Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter